...
oabi-img

OmniAb Inc., Common Stock

OABI

NMQ

$3.79

-$0.21

(-5.25%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$490.10M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
438.46K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.44
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.56 L
$6.71 H
$3.79

About OmniAb Inc., Common Stock

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameOABISectorS&P500
1-Week Return-5.72%-2.27%-0.57%
1-Month Return-6.88%-3.96%1.21%
3-Month Return-15.96%-9.7%7.57%
6-Month Return-10.19%-3.37%11.45%
1-Year Return-30.07%3.71%28.48%
3-Year Return-62.1%3.8%29.52%
5-Year Return-61.17%39.78%90.66%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue18.32M23.27M34.75M59.08M34.16M[{"date":"2019-12-31","value":31.01,"profit":true},{"date":"2020-12-31","value":39.39,"profit":true},{"date":"2021-12-31","value":58.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":57.83,"profit":true}]
Cost of Revenue--14.97M16.25M19.50M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":76.77,"profit":true},{"date":"2022-12-31","value":83.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit18.32M23.27M19.78M42.83M34.16M[{"date":"2019-12-31","value":42.77,"profit":true},{"date":"2020-12-31","value":54.33,"profit":true},{"date":"2021-12-31","value":46.19,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.77,"profit":true}]
Gross Margin100.00%100.00%56.92%72.49%100.00%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":56.92,"profit":true},{"date":"2022-12-31","value":72.49,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses31.34M48.89M70.36M85.72M103.58M[{"date":"2019-12-31","value":30.26,"profit":true},{"date":"2020-12-31","value":47.2,"profit":true},{"date":"2021-12-31","value":67.92,"profit":true},{"date":"2022-12-31","value":82.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(13.03M)(25.62M)(35.61M)(26.65M)(69.42M)[{"date":"2019-12-31","value":-1302700000,"profit":false},{"date":"2020-12-31","value":-2562300000,"profit":false},{"date":"2021-12-31","value":-3560900000,"profit":false},{"date":"2022-12-31","value":-2664800000,"profit":false},{"date":"2023-12-31","value":-6941900000,"profit":false}]
Total Non-Operating Income/Expense818.00K1.89M1.25M1.17M9.52M[{"date":"2019-12-31","value":8.6,"profit":true},{"date":"2020-12-31","value":19.86,"profit":true},{"date":"2021-12-31","value":13.16,"profit":true},{"date":"2022-12-31","value":12.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(13.03M)(23.73M)(34.35M)(26.06M)(64.36M)[{"date":"2019-12-31","value":-1302700000,"profit":false},{"date":"2020-12-31","value":-2372800000,"profit":false},{"date":"2021-12-31","value":-3435000000,"profit":false},{"date":"2022-12-31","value":-2606100000,"profit":false},{"date":"2023-12-31","value":-6436300000,"profit":false}]
Income Taxes562.00K(6.17M)(7.31M)(3.73M)(13.74M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-1098.04,"profit":false},{"date":"2021-12-31","value":-1300.36,"profit":false},{"date":"2022-12-31","value":-663.17,"profit":false},{"date":"2023-12-31","value":-2445.55,"profit":false}]
Income After Taxes(13.59M)(17.56M)(27.04M)(22.33M)(50.62M)[{"date":"2019-12-31","value":-1358900000,"profit":false},{"date":"2020-12-31","value":-1755700000,"profit":false},{"date":"2021-12-31","value":-2704200000,"profit":false},{"date":"2022-12-31","value":-2233400000,"profit":false},{"date":"2023-12-31","value":-5061900000,"profit":false}]
Income From Continuous Operations(13.59M)(17.56M)(27.04M)(22.33M)(29.75M)[{"date":"2019-12-31","value":-1358900000,"profit":false},{"date":"2020-12-31","value":-1755700000,"profit":false},{"date":"2021-12-31","value":-2704200000,"profit":false},{"date":"2022-12-31","value":-2233400000,"profit":false},{"date":"2023-12-31","value":-2974600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(13.59M)(17.56M)(27.04M)(22.33M)(50.62M)[{"date":"2019-12-31","value":-1358900000,"profit":false},{"date":"2020-12-31","value":-1755700000,"profit":false},{"date":"2021-12-31","value":-2704200000,"profit":false},{"date":"2022-12-31","value":-2233400000,"profit":false},{"date":"2023-12-31","value":-5061900000,"profit":false}]
EPS (Diluted)--(0.02)(0.24)(0.53)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-2,"profit":false},{"date":"2022-12-31","value":-24,"profit":false},{"date":"2023-12-31","value":-53,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

OABI
Cash Ratio 4.12
Current Ratio 4.62

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

OABI
ROA (LTM) -13.76%
ROE (LTM) -20.45%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

OABI
Debt Ratio Lower is generally better. Negative is bad. 0.12
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.88

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

OABI
Trailing PE NM
Forward PE NM
P/S (TTM) 22.47
P/B 1.57
Price/FCF NM
EV/R 20.73
EV/Ebitda NM

FAQs

What is OmniAb Inc. share price today?

OmniAb Inc. (OABI) share price today is $3.79

Can Indians buy OmniAb Inc. shares?

Yes, Indians can buy shares of OmniAb Inc. (OABI) on Vested. To buy OmniAb Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OABI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of OmniAb Inc. be purchased?

Yes, you can purchase fractional shares of OmniAb Inc. (OABI) via the Vested app. You can start investing in OmniAb Inc. (OABI) with a minimum investment of $1.

How to invest in OmniAb Inc. shares from India?

You can invest in shares of OmniAb Inc. (OABI) via Vested in three simple steps:

  • Click on Sign Up or Invest in OABI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in OmniAb Inc. shares
What is OmniAb Inc. 52-week high and low stock price?

The 52-week high price of OmniAb Inc. (OABI) is $6.71. The 52-week low price of OmniAb Inc. (OABI) is $3.56.

What is OmniAb Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of OmniAb Inc. (OABI) is

What is OmniAb Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of OmniAb Inc. (OABI) is 1.57

What is OmniAb Inc. dividend yield?

The dividend yield of OmniAb Inc. (OABI) is 0.00%

What is the Market Cap of OmniAb Inc.?

The market capitalization of OmniAb Inc. (OABI) is $490.10M

What is OmniAb Inc.’s stock symbol?

The stock symbol (or ticker) of OmniAb Inc. is OABI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top